Contract Medical Device Manufacturing
Total Trials
7
As Lead Sponsor
As Collaborator
0
Total Enrollment
804
NCT01457781
Inhaled Nitric Oxide/INOpulse DS for Pulmonary Arterial Hypertension (PAH)
Phase: Phase 2
Role: Lead Sponsor
Start: Apr 30, 2012
Completion: Jul 31, 2016
NCT01728220
Two-Part Dose-Confirming Study of Pulsed Inhaled Nitric Oxide in Subjects With WHO Group 3 Pulmonary Hypertension Associated With COPD
Start: Dec 31, 2012
Completion: Jul 31, 2014
NCT02652429
Long-Term Extension Study of Inhaled Nitric Oxide (iNO) for PAH
Phase: Phase 3
Start: Mar 31, 2016
Completion: Dec 31, 2023
NCT02725372
Clinical Study of Pulsed, Inhaled Nitric Oxide Versus Placebo in Symptomatic Subjects With PAH
Start: Apr 30, 2016
Completion: Aug 31, 2018
NCT03602781
Study of PAH Subjects With LTOT Use That Have Demonstrated Improved Exercise Tolerance With the Use of Inhaled Nitric
Start: Aug 31, 2018
Completion: Jun 30, 2020
NCT04421508
A Study to Assess Pulsed Inhaled Nitric Oxide vs Placebo in Subjects With Mild or Moderate COVID-19
Start: Jul 12, 2020
Completion: Jan 22, 2021
NCT03267108
A Study to Assess Pulsed Inhaled Nitric Oxide in Subjects With Pulmonary Fibrosis at Risk for Pulmonary Hypertension
Start: Dec 14, 2020
Completion: Jun 30, 2023
Loading map...